Medtronic (MDT) ended the recent trading session at $92.20, demonstrating a +0.93% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 1.04%.

Here are five headlines to know about Medtronic, as reported by Becker's since Jan. 7: 1. Medtronic acquired rights and intellectual property related to Nanovis' Sites Medical's OsteoSync titanium ...

Medtronic will use the technology to develop PEEK interbody spine fusion devices that enhance implant fixation.

When Geoff Martha, chairman and CEO of Medtronic, took over the medical device maker’s Restorative Therapies Group in 2015, ...

Bloomberg Law reported earlier this week that Medtronic and Axonics — now part of Boston Scientific — settled their ...

Nanovis announced today that it sold certain nano surface technology assets and certain IP rights to Medtronic.

Scientists are now speculating that the first person to live to 150 years may already be among us. But where might this ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Medtronic (MDT – Research Report), Biohaven Ltd. (BHVN – ...

Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Canopy Growth (CGC – Research Report), ...